ã¯ã¯ãã³ã¨æ»äº¡ã¨ã®å æé¢ä¿
ä¸è¨ã®è³æ1ã¨è³æ2ãæ¯ã¹ã¦ããããã¨æãã¾ãããï¼Â
æ²»é¨ã§ã¯18人ã¨ãã¯ã¯ãã³æ»ã§ã¯ãªãã¨ãããå®ç¨åå¾ã®æ»äº¡ã¯99%ããå æé¢ä¿ãä¸æãã¨ããã¦ãããã§ãã
æ²»é¨ã§æ»äº¡ãåºãã¨å®ç¨åãé£ãããªãããããã¼ã¿å½è£
ã®ãããªãã¨ããã¦ããã®ã§ã¯ã¨çã£ã¦ãã¾ãã¾ãã
è³æ1ï¼æ²»é¨ã§ã®æ»äº¡ä¾ï¼ã³ã¹ã¿ã¤ãï¼ - 24ãã¼ã¸
https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_3.pdf
18人ãæ»äº¡ããå
¨ã¦ã®ã±ã¼ã¹ã§æ²»é¨è¬ã¨ã®å æé¢ä¿ãå¦å®ãããã
è³æ2ï¼å®ç¨åå¾ã®æ»äº¡ä¾ï¼ã³ãããã£ï¼ - 1ãã¼ã¸
https://www.mhlw.go.jp/content/10601000/001161432.pdf
1878件ã®æ»äº¡ä¾ã®ãã¡99%ã«å½ãã1866件ãã¯ã¯ãã³ã¨ã®å æé¢ä¿ãä¸æã¨ãããã
Â